- Last edited on February 1, 2024
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Previous revision | ||
cl:1-delirium [on May 21, 2019] |
cl:1-delirium [on August 25, 2019] |
||
---|---|---|---|
Line 12: | Line 12: | ||
<panel type="info" title="Delirium Risk Factors" no-body="true"> | <panel type="info" title="Delirium Risk Factors" no-body="true"> | ||
^ Modifiable Essentials ^ Modifiable Medical ^ Non-modifiable ^ | ^ Modifiable Essentials ^ Modifiable Medical ^ Non-modifiable ^ | ||
- | | • Sensory impairment (hearing or vision)\\ • Immobilization (catheters or restraints)\\ • Environment (for example, admission to an intensive care unit)\\ • [[pain-medicine:home|Pain]]\\ • Emotional distress\\ • Sustained sleep deprivation | • Medications (e.g. - [[addictions:sedative-hypnotics|sedative hypnotics]], narcotics, [[meds:toxidromes:anticholinergic-cholinergic|anticholinergic]] drugs, corticosteroids, polypharmacy, **[[addictions:alcohol|alcohol withdrawal]]** or other drugs)\\ • Acute neurological diseases (e.g. - acute stroke [usually right parietal], intracranial hemorrhage, meningitis, [[psychosis:anti-nmda-receptor-encephalitis|encephalitis]])\\ • Ongoing illness (e.g. - infection, iatrogenic complications, acute illness, anemia, dehydration, poor nutrition, trauma, fractures, HIV)\\ • Metabolic derangement\\ • Surgery | • [[geri:dementia:home|Dementia]] or cognitive impairment\\ • Advancing age (>65 years)\\ • History of delirium, stroke, neurological disease, falls or gait disorder\\ • Multiple comorbidities\\ • Male sex\\ • Chronic renal or hepatic disease | | + | | • Sensory impairment (hearing or vision)\\ • Immobilization (catheters or restraints)\\ • Environment (for example, admission to an intensive care unit)\\ • [[pain-medicine:home|Pain]]\\ • Emotional distress\\ • Sustained sleep deprivation | • Medications (e.g. - [[addictions:sedative-hypnotics|sedative hypnotics]], narcotics, [[meds:toxidromes:anticholinergic-cholinergic|anticholinergic]] drugs, corticosteroids, polypharmacy, **[[addictions:alcohol|alcohol withdrawal]]** or other drugs)\\ • Acute neurological diseases (e.g. - acute stroke [usually right parietal], intracranial hemorrhage, meningitis, [[cl:0-autoimmune-encephalitis|encephalitis]])\\ • Ongoing illness (e.g. - infection, iatrogenic complications, acute illness, anemia, dehydration, poor nutrition, trauma, fractures, HIV)\\ • Metabolic derangement\\ • Surgery | • [[geri:dementia:home|Dementia]] or cognitive impairment\\ • Advancing age (>65 years)\\ • History of delirium, stroke, neurological disease, falls or gait disorder\\ • Multiple comorbidities\\ • Male sex\\ • Chronic renal or hepatic disease | |
</panel> | </panel> | ||
Line 112: | Line 112: | ||
</callout> | </callout> | ||
- | ==== Depression, Delirium, or Dementia? ==== | + | ==== Dementia, Depression, or Delirium? ==== |
- | <alert icon="fa fa-arrow-circle-right fa-lg fa-fw" type="success">See also: **[[geri:dementia:home|]]**, **[[mood:1-depression:geriatric|]]**, [[cl:1-delirium|]]</alert> | + | <alert icon="fa fa-arrow-circle-right fa-lg fa-fw" type="success">See also: **[[geri:dementia:home|]]**, **[[mood:1-depression:geriatric|]]**, and [[cl:1-delirium|]]</alert> |
In the geriatric population, it is important to differentiate between delirium, dementia, and depression, which can be difficult to distinguish.[([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1124165/|Brown, T. M., & Boyle, M. F. (2002). Delirium. Bmj, 325(7365), 644-647.]])][([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535349/|Fong, T. G., Davis, D., Growdon, M. E., Albuquerque, A., & Inouye, S. K. (2015). The interface of delirium and dementia in older persons. The Lancet. Neurology, 14(8), 823.]])][([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065676/table/T1/?report=objectonly|Fong, T. G., Tulebaev, S. R., & Inouye, S. K. (2009). Delirium in elderly adults: diagnosis, prevention and treatment. Nature reviews neurology, 5(4), 210.]])] The prevalence of delirium superimposed on dementia ranges anywhere from 22% to 89% of hospitalized and community populations aged 65 and older with dementia. The negative outcomes of these co-occuring conditions include accelerated and long-term cognitive, functional decline, institutionalization, re-hospitalization, and increased mortality.[([[https://www.ncbi.nlm.nih.gov/pubmed/12366629|Fick, D. M., Agostini, J. V., & Inouye, S. K. (2002). Delirium superimposed on dementia: a systematic review. Journal of the American Geriatrics Society, 50(10), 1723-1732.]])] | In the geriatric population, it is important to differentiate between delirium, dementia, and depression, which can be difficult to distinguish.[([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1124165/|Brown, T. M., & Boyle, M. F. (2002). Delirium. Bmj, 325(7365), 644-647.]])][([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535349/|Fong, T. G., Davis, D., Growdon, M. E., Albuquerque, A., & Inouye, S. K. (2015). The interface of delirium and dementia in older persons. The Lancet. Neurology, 14(8), 823.]])][([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065676/table/T1/?report=objectonly|Fong, T. G., Tulebaev, S. R., & Inouye, S. K. (2009). Delirium in elderly adults: diagnosis, prevention and treatment. Nature reviews neurology, 5(4), 210.]])] The prevalence of delirium superimposed on dementia ranges anywhere from 22% to 89% of hospitalized and community populations aged 65 and older with dementia. The negative outcomes of these co-occuring conditions include accelerated and long-term cognitive, functional decline, institutionalization, re-hospitalization, and increased mortality.[([[https://www.ncbi.nlm.nih.gov/pubmed/12366629|Fick, D. M., Agostini, J. V., & Inouye, S. K. (2002). Delirium superimposed on dementia: a systematic review. Journal of the American Geriatrics Society, 50(10), 1723-1732.]])] |